In item 3, the Board of Directors asks for the authorization to purchase up to 7 million treasury shares (3.4% of the share capital), at a maximum price of €20.0 per share. While ECGS acknowledges that the Company is currently well capitalized, it considers that the potential impact of the Covid-19 induced crisis is not yet known. Therefore, we consider that it is not appropriate to seek approval for a new buyback programme. Therefore, we recommend shareholders to oppose. In item 11, s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.